HowShorted

How shorted is TG THERAPEUTICS, INC.?

More shorted than 95% of the 2,877 ranked US companies

19.15%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
−0.90
5 reports (~10 weeks)
+0.79
Aggregate net short position time series for TG THERAPEUTICS, INC.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202619.15%−0.90
15 Jul 202620.05%+0.34
30 Jun 202619.71%−0.02
15 Jun 202619.73%+1.32
29 May 202618.41%+0.05
15 May 202618.36%+1.34
30 Apr 202617.02%−1.07
15 Apr 202618.09%−0.14
31 Mar 202618.23%+0.50
13 Mar 202617.73%+0.39
27 Feb 202617.34%−1.12
13 Feb 202618.46%+0.22
30 Jan 202618.24%+1.05
15 Jan 202617.19%+1.08
31 Dec 202516.11%+0.29
15 Dec 202515.82%+0.01
28 Nov 202515.81%−0.08
14 Nov 202515.89%+1.04
31 Oct 202514.85%−0.16
15 Oct 202515.01%+0.13
30 Sep 202514.88%−0.62
15 Sep 202515.50%+0.05
29 Aug 202515.45%+0.61
15 Aug 202514.84%−0.08
31 Jul 202514.92%–

Frequently asked questions

How shorted is TG THERAPEUTICS, INC. right now?
19.15% of TG THERAPEUTICS, INC.'s (TGTX) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.